Healthcare (Prescription Drugs)

Wyoming's SF 19 allows schools to stock and administer epinephrine using auto-injectors, nasal sprays, or other FDA-approved devices for severe allergic reactions without requiring a student-specific prescription. It directly affects schools, school nurses, and trained staff by enabling them to provide emergency treatment to students experiencing anaphylaxis. The bill requires schools to develop allergy management guidelines, track incidents, and maintain records of trained personnel, while also providing liability protection for good-faith administration (excluding gross negligence). It updates definitions to include all approved epinephrine delivery methods and specifies that administering stock epinephrine does not constitute the practice of medicine.